Your browser doesn't support javascript.
loading
Inhibition of glutamate oxaloacetate transaminase 1 in cancer cell lines results in altered metabolism with increased dependency of glucose.
Zhou, Xiaoshan; Curbo, Sophie; Li, Fuqiang; Krishnan, Shuba; Karlsson, Anna.
  • Zhou X; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Curbo S; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Li F; BGI-Shenzhen, Beishan Industrial Zone, 518083 Yantian District, Shenzhen, China.
  • Krishnan S; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Karlsson A; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, 141 86, Stockholm, Sweden. anna.karlsson@ki.se.
BMC Cancer ; 18(1): 559, 2018 May 11.
Article en En | MEDLINE | ID: mdl-29751795
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aspartato Aminotransferasa Citoplasmática / Reprogramación Celular / Glucosa / Neoplasias Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aspartato Aminotransferasa Citoplasmática / Reprogramación Celular / Glucosa / Neoplasias Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article